Email Updates

You are here

MTN 042

Status
Planned
Phase
III
Objective

Phase 3b, Randomized, Open Label Safety and Pharmacokinetic Trial of Dapivirine Vaginal Ring (VR) and Oral FTC/TDF Use in Pregnancy

Prevention Option(s)
Microbicides
Arms and Assigned Interventions
Mode of Delivery
Gel
Tablet
Products
Dapivirine Ring
TDF/FTC (Truvada)
Enrollment
750
18
Years
45
Years
Population
Women
Sites

Blantyre CRS

Malawi

WRHI CRS

South Africa

MU-JHU Research Collaboration CRS

Kampala
Uganda

Zengeza CRS

Harare
Zimbabwe